BOULDER, Colo., Aug. 2 /PRNewswire-FirstCall/ -- Tapestry Pharmaceuticals, Inc. announced today that it will host a conference call on Thursday, August 9, 2007 at 9:00 a.m. Eastern Time (7:00 a.m. Mountain Time) to review the Company’s second quarter 2007 financial results and provide a company update. The Company will issue a press release regarding its second quarter financial results on the same day, prior to the conference call.
To participate in the conference call, please dial 800-599-9795 (domestic) or 617-786-2905 (international) and reference the access code 29185656. A replay of the call will be available from 11:00 a.m. Eastern Time on August 9, 2007 until August 16, 2007 at midnight Eastern Time. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international) and reference the access code 85506220. A live audio webcast of the call will also be available on the “Investors” section of the Company’s website, http://www.tapestrypharma.com. An archived webcast will be available on the Tapestry website for approximately 30 days after the event.
About Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of proprietary therapies for the treatment of cancer. For more information about Tapestry and its technologies, visit Tapestry’s web site at http://www.tapestrypharma.com.
Contact: Tapestry Pharmaceuticals, Inc. Gordon Link Senior Vice President, Chief Financial Officer 303-516-8500 glink@tapestrypharma.com Investor: Lilian Stern Stern Investor Relations, Inc. 212-362-1200 lilian@sternir.com Media: Dana Conti Schwartz Communications, Inc. 781-684-0770 tapestry@schwartz-pr.com
Tapestry Pharmaceuticals, Inc.
CONTACT: Gordon Link, Senior Vice President, Chief Financial Officer ofTapestry Pharmaceuticals, Inc., +1-303-516-8500, glink@tapestrypharma.com;or Investor, Lilian Stern of Stern Investor Relations, Inc., for TapestryPharmaceuticals, Inc., +1-212-362-1200, lilian@sternir.com; or Media, DanaConti of Schwartz Communications, Inc., for Tapestry Pharmaceuticals, Inc.,+1-781-684-0770, tapestry@schwartz-pr.com
Web site: http://www.tapestrypharma.com/
